BiotechTube
Home/BlueHaven Therapeutics/Marco G. Renoldi
MG

Marco G. Renoldi

Chief Executive Officer

BlueHaven Therapeutics

Therapeutic Areas

Oncology

BlueHaven Therapeutics Pipeline

DrugIndicationPhase
Lead Program (unspecified)Glioblastoma (GBM)Preclinical

Leadership Team at BlueHaven Therapeutics

JD
Jostein Dahle
Co-founder and Chief Technology Officer
LS
Luca Sereni
Co-founder and Chief Operating Officer
MD
Michael Dornish
Co-founder and Chief Scientific Officer
SP
Stefania Poli
Chief People Officer
View full BlueHaven Therapeutics profile